New phaco device

Oertli launched the CataRhex 3 phaco device at the XXXI Congress of the ESCRS in Amsterdam, The Netherlands. "Weighing as little as 5kg and fitting in any pilot case, CataRhex 3® can be mounted on any IV pole with a click – it is thus the epitome of portable equipment," said a company spokeswoman. "A device that takes up so little space and is so easy to handle is becoming increasingly attractive in both outpatient and high-volume clinics," she said. "Efficiency and safety start with ease of operation. Displays and tactile keys are visible at a glance, all connections can be operated from the front, with the ergonomic multi-function pedal immediately responding to any foot movement. CataRhex 3 is a power pack with cutting-edge technology," said the spokeswoman.
www.oertli-catarhex3.com
Latest Articles
Addressing Postoperative Visual Complications
Managing aberrations after laser refractive surgery requires a multi-layered approach.
3D Printing Helps Transform Ukrainian Eye Care
The country’s ophthalmologists offer valuable experience in treating ocular trauma and prosthesis design.
Winning Essay Says ‘Collective Desire’ Must Drive DEI Implementation
Emerging Microbial Trends That Could Affect Your Practices
A triptych of challenges paints a concerning picture for ophthalmologists across the globe.
Improving Outcomes with Laser-Assisted Surgery
Femtosecond laser offers a multifunctional tool for improving the safety and efficacy of cataract and refractive lens exchange procedures.
Could the Corneal Transplant Pool Increase?
Modifying or discarding major contraindications for keratoplasty could mean more patients have their sight restored.
Matching Premium IOLs to Visual Lifestyles
From monofocal to full-range solutions, each practice needs comprehensive understanding.
Going Dutch on Acanthamoeba Keratitis
A world-first trial suggests a new medication could beat the disease.
Avoiding Intracorneal Ring Segment Complications
Femtosecond lasers are helping improve refractive results with fewer problems.